CALCA and cancer: Among cancer patients, those who had advanced stage IV had a higher median PCT levels than those with stage I-III (0.190 ng/ml [range 0–154.7] vs. 0.127 ng/ml [range 0–18.13]; p = 0.004) (Table 2).